ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Key progress has been achieved in many clinical trials of Abexinostat.
June 27, 2023How much progress has been made in the research and development of HDAC inhibitor? -
OnKure, Pfizer collaborate to evaluate combination of OKI-179 and binimetinib
September 27, 2020OnKure, a leader in discovery and development of next generation histone deacetylase (HDAC) inhibitors, entered into a clinical trial collaboration and supply agreement with Pfizer to support the clinical proof of concept study for MEKTOVI (binimetinib).. -
PCM-075 Demonstrates Synergy with HDAC Inhibitor in Non-Hodgkin Lymphoma Cell Lines
August 22, 2017Trovagene announced compelling results of preclinical research of PCM-075 with a Histone deacetylase (HDAC) inhibitor in Non-Hodgkin Lymphoma (NHL) cell lines.
Pharma Sources Insight January 2025
